Transport of a psychiatric patient following an acute psychotic episode abroad

A 20-year-old Brazilian male developed an acute psychiatric emergency while on vacation with his family in Egypt. On 24 December 2025, he was admitted to an emergency department after a suicide attempt and aggressive behaviour toward family members, reportedly following commands from auditory hallucinations described as a form of “revelation”.

On admission, the patient presented with marked psychomotor agitation, which was successfully de-escalated, allowing for a full psychiatric assessment. He reported a two-year history of auditory hallucinations, previously perceived as non-threatening. This episode represented the first instance in which the hallucinations issued commands to harm himself or others, as well as to refuse food.

The patient disclosed a past history of illicit drug use, claiming abstinence for over one year; however, a urine toxicology screen was positive for tramadol. He subsequently underwent a threeweek psychiatric hospitalisation in Cairo, receiving antipsychotic medication and electroconvulsive therapy (ECT), with good clinical response.

Indication for aeromedical transport

Despite clinical stabilisation, the patient was considered unfit for commercial air travel due to the high risk of psychiatric decompensation associated with a long, multi-leg journey and the need for continuous medical supervision while sedated. Aeromedical evacuation was therefore indicated and coordinated by Brasil Vida Táxi Aéreo, ensuring a controlled environment and specialised medical support.

At pre-flight assessment, the patient was calm, cooperative, and demonstrated good insight and impulse control. There was no active suicidal or aggressive ideation.

He remained psychiatrically stable during all phases of the flight

Mission profile and logistics

The aeromedical mission departed from Goiânia, Brazil, on 30 December 2025, utilising a Gulfstream G100 configured for aeromedical transport. The return flight occurred on 2 January 2026, with refuelling stops in Almería (Spain), Sal Island (Cabo Verde), and Fortaleza, concluding with patient disembarkation in São Paulo, Brazil.

In-flight management and outcome

During transport, antipsychotic therapy was maintained according to the established treatment plan. The patient underwent periodic reassessment throughout.

He remained psychiatrically stable during all phases of the flight. No chemical or mechanical restraints were required. Nevertheless, the potential need for restraint was discussed with the family prior to departure, prioritising transparency and safety.

Upon arrival in São Paulo, the patient was stable, calm, and cooperative, and suitable for transfer to a psychiatric facility for continued inpatient care.

Discussion

The aeromedical transport of patients with severe psychiatric disorders presents unique challenges. Psychiatric symptoms may fluctuate rapidly and are often exacerbated by stressors inherent to air travel.

Pre-flight psychiatric assessment is essential to evaluate symptom stability, insight, and impulse control. Such decisions must be individualised, prioritising patient dignity and safety while ensuring the protection of the medical crew.

Additionally, the onset of acute psychiatric illness outside the patient’s country of origin significantly increases emotional distress for both patients and families. Cultural differences, language barriers, and unfamiliar healthcare systems often intensify anxiety and urgency.